Medical Device | March 16, 2023
Biocorp and HRA Pharma to jointly develop a medical device innovation
Biocorp will receive an initial milestone payment this year
Biocorp will receive an initial milestone payment this year
Spain’s renowned centre of excellence recognises importance of verifying radiosurgery plans ahead of patient treatment
For the first-line treatment of patients with unresectable advanced or metastatic malignant pleural mesothelioma
Twelve hospitals across India will be part of the network which will support the trial in India
The British-Swedish pharma major certainly has a strong competitive edge for BTC treatment in the country
N-nitroso dimethylamine (NDMA) is a probable human carcinogen and tts effects on humans rely on observational studies.
Projected ~US$100 million cash balance of combined company expected to fund operations through mid-2025 and to clinical data over the next 12 to 24 months
Designation based on positive data from Phase 2b KEYNOTE-942/mRNA-4157-P201 trial
A total of 889 M&A deals were announced in the medical devices sector in 2022 worth $93 billion
This action follows the recent acceptance of the Marketing Authorization Application (MAA) for Pfizer’s RSV vaccine candidate by the European Medicines Agency
Subscribe To Our Newsletter & Stay Updated
